Abstract
Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled SSTR-RADS version 1.0, which might serve as a standardized assessment for both diagnosis and treatment planning in neuroendocrine tumors. SSTR-RADS could guide the imaging specialist in interpreting SSTR PET scans, facilitate communication with the referring clinician so that appropriate workup for equivocal findings is pursued, and serve as a reliable tool for patient selection for planned peptide receptor radionuclide therapy.
Original language | English |
---|---|
Pages (from-to) | 1085-1091 |
Number of pages | 7 |
Journal | Journal of Nuclear Medicine |
Volume | 59 |
Issue number | 7 |
DOIs | |
State | Published - 1 Jul 2018 |
Externally published | Yes |
Keywords
- Ga-DOTATATE/-TOC
- Neuroendocrine tumor
- PET
- PRRT
- Peptide receptor radionuclide therapy
- RADS
- SSTR
- Somatostatin receptor